Larger text
Smaller text
J&J wins U.S. approval for TB tablet
About The Tribune-Review
Daily Photo Galleries
By Anna Edney C.2012 Bloomberg News
Published: Monday, December 31, 2012, 10:30 p.m.
Updated: Tuesday, February 19, 2013
Johnson & Johnson won regulatory approval for its tuberculosis tablet Sirturo, the first drug in 40 years that provides a new way to treat the contagious lung infection.
The Food and Drug Administration cleared Sirturo to be added to therapies for use by adults whose illness is resistant to multiple medicines, the New Brunswick, N.J.- based company said Monday.
While tuberculosis was once the leading cause of death in the nation, the drug-resistant version of the illness affected about 98 people last year, according to the Centers for Disease Control and Prevention.
Most Popular Business Headlines
- Americans fail to find jobs as firms hire foreigners
- Automated teller machine fees up 20 percent in 5 years
- As yen falls, so does cost of products from Japan
- Pa. jobless rate declines as fewer look for work
- PPG Corning bankruptcy plan receives preliminary approval
- Web giants likely to battle for music fans’ attention
- Federal regulators say Consol can reopen fire-stricken mine
- Year after IPO, Facebook aims to be ad colossus
- Blairsville-area company finds 2nd calling in shale gas service industry
- Idaho spud giant bets on biotech potatoes
- Government OKs Texas LNG plan
You must be signed in to add comments
To comment, click the Sign in or sign up at the very top of this page.
Subscribe today! Click here for our subscription offers.
